Aethlon Medical names new president

Aethlon Medical, Inc., a creator of therapeutic filtration devices that target cancer-causing agents and infectious disease, has announced that Rod Kenley has been named company president.

Kenley recently joined the Board of Directors at Aethlon and will continue to remain as an inside director.

“We are extremely pleased to have Rod become a full-time member of our team,” Jim Joyce, CEO and former President of Aethlon, said, “As referenced when he joined our board, Rod has been instrumental in commercializing some of the most important advances in the dialysis industry. He is among the best in industry talent, whose full focus towards our endeavors will immediately impact our business and improve our efficiency in advancing established and future opportunities.”

Kenley has been a part of the healthcare industry for 33 years, most of them in the extracorporeal blood purification field. During his 13 years at Baxter Healthcare (Travenol), he conceived of and managed the launch of multiple commercially successful products, including the HomeChoice peritoneal dialysis center. In 1991, Kenley left Baxter to form Aksys Ltd. to commercialize and create a daily home hemodialysis system called the PHD system.

Kenley has received over 30 patents and he has frequently presented at international symposia on the subject of dialysis, designing medical equipment to FDA guidelines and the design of dialysis equipment.

Aethlon Medical is best-known for the Hemopurifier, the first medical device to target removing immunosuppressive proteins and infectious viruses from the circulatory system.